MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
SHW HOLD REF $344 PW TARGET $341 -1% Single-name research · 1 July 2026
Equity ResearchMaterials · Specialty Chemicals
SHW

Sherwin-Williams Co (SHW)

The bull case — 'Bull — Cycle + Re-Rate' (8% weight) — targets $605, +76% vs spot. It needs Gross Margin to surprise to the upside.

Verdict
HOLD
Triangulated fair value $275
Reference
$344
Close · 1 July 2026
PW Target
$341 -1%
Probability-weighted
Horizon
12 mo
MCH Advisory
$275
Fair value
$341
Scenario PWEV
29.3x
Forward P/E
$85B
Market cap
$290 – $377
52-week range
Contents

Rating: HOLD

Metric Value
Current Price $344
Triangulated Fair Value $275
12-mo Scenario PWEV $341
Implied Return -20%
Forward P/E 29.3x
Market Cap $85B
52-Week Range $290 – $377

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

Investment Thesis

The bull case — 'Bull — Cycle + Re-Rate' (8% weight) — targets $605, +76% vs spot. It needs Gross Margin to surprise to the upside.

The dashboard below is the whole argument on one page: spot ($344) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $344 spot from $212 to $341 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The five valuation anchors bracket the $344 spot from $212 to $341 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The structural case — 'Structural — Brand / Volume Erosion' (20%) — targets $146, -57% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.

Key Debate

Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.29 vs analyst floor +0.00 → delta +0.29 (n=31 mgmt / 20 Q&A; 31th pctile across the S&P book, z -0.6).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q1 +0.29 +0.00 +0.29
2025Q4 +0.37 +0.00 +0.37
2025Q3 +0.45 +0.20 +0.26
2025Q2 +0.25 +0.01 +0.25

News (last 365d, 1000 articles): avg ticker sentiment +0.18 (bullish 26% / bearish 4%)

Scenario Analysis

The tree runs from a structural 'Structural — Brand / Volume Erosion' downside ($146) to a 'Bull — Cycle + Re-Rate' bull case ($605); the probability-weighted blend (PWEV $341) is -1% versus spot.

Scenario Probability Target Return
Structural — Brand / Volume Erosion 20% $146 -57%
Downturn — Construction / Industrial Slump 18% $255 -26%
Base — Pricing-Led Compounding 33% $355 +3%
Growth — Share Gains + Mix 21% $479 +39%
Bull — Cycle + Re-Rate 8% $605 +76%
Probability-Weighted (PWEV) $341 -1%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Brand / Volume Erosion (20%, $146). Structural impairment — raw-material squeeze / volume loss: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 146.43; probability: 0.2.
  • Downturn — Construction / Industrial Slump (18%, $255). Cyclical downturn — coatings/specialty volumes + raw-material spread + pricing power weakens for 1–2 years before normalising. Drivers — implied_target: 255.45; probability: 0.18.
  • Base — Pricing-Led Compounding (33%, $355). Mid-cycle — normalised coatings/specialty volumes + raw-material spread + pricing power; disciplined capital allocation; steady returns. Drivers — implied_target: 354.8; probability: 0.33.
  • Growth — Share Gains + Mix (21%, $479). Upside — share gains + input deflation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 478.98; probability: 0.21.
  • Bull — Cycle + Re-Rate (8%, $605). Upside tail — sustained tight conditions or a structural re-rate on share gains + input deflation. Drivers — implied_target: 604.93; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $344 spot; PWEV $341 (-1%). the payoff is skewed to the upside — upside to $605 against downside to <img src=
Five-scenario tree. Probability-weighted targets around the $344 spot; PWEV $341 (-1%). the payoff is skewed to the upside — upside to $605 against downside to $146

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $304 -12%
Peer P/E re-rate multiple $212 -38%
Peer EV/Revenue re-rate multiple $205 -41%
Scenario PWEV multiple $341 -1%
DCF (5-year + terminal) cash flow + terminal × $234 -32%
Triangulated (weighted) $275 -20%

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $304 + scenario PWEV $341, ≈ spot); the weighted blend $275 (-20%) sits below it because the cash-flow DCF ($234) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $304 and 39% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (51% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median $304; P(price &gt; current) 39%. P10–P90: <img src=
Monte Carlo distribution. Median $304; P(price > current) 39%. P10–P90: $152–$529.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.5%, 25x terminal FCF multiple → $234. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 8.5%, 25x terminal → $234.
Independent DCF. WACC 8.5%, 25x terminal → $234.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 18.015x) implies $212. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 18.015x → $212; EV/Rev re-rate → $205.
Cross-sectional peer benchmarking. Peer-median fwd P/E 18.015x → $212; EV/Rev re-rate → $205.

Across all anchors the spread is wide (genuine disagreement — low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin Multiple Capex % Tag
Specialty Chemicals / Coatings $23.9B 100% 5% 15% 29x 4% ESTIMATE

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver coatings/specialty volumes + raw-material spread + pricing power
net_debt_or_cash_b -13.57

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.04
div_yield 0.0095

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside raw-material squeeze / volume loss
upside share gains + input deflation

Industry Context — Materials — Quality

This name sits in the Materials — Quality as a coatings. coatings/specialty volumes + raw-material spread + pricing power Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: LIN (gases) · SHW (coatings) · ECL (coatings) · APD (gases) · CTVA (ag_specialty) · PPG (coatings) · IFF (coatings) · DD (coatings)

Shared state Capex path House view This name implies
Industrial Recession — Demand / De-Rate 38% 38%
Mid-Cycle — Steady Compounding 33% 33%
Expansion — Volume + Pricing Upside 29% 29%

On the cluster's key downside — Industrial Recession — Demand / De-Rate () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The quality cycle is the shared macro driver. Driver — global industrial demand + pricing power (gases, coatings, specialty/ag) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $25B $4B $1B $1B $3B $3B
FY+2 $26B $4B $1B $1B $3B $3B
FY+3 $27B $4B $1B $1B $3B $3B
FY+4 $29B $5B $1B $1B $3B $2B
FY+5 $29B $5B $1B $1B $4B $2B
Terminal $4B × 25x $59B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $13B + PV(terminal) $59B = EV $71B; + net cash → equity $58B ÷ diluted shares 0.25B = $234/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $159/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 12% vs WACC 8% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
ECL 5.34x 33.56x 5% 17%
PPG 2.071x 15.46x 5% 14%
IFF 2.321x 16.69x 5% 10%
DD 3.045x 19.34x 5% 14%
Median 2.683x 18.015x

Peer-median fwd P/E → $212; EV/Rev → $205.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $234 41% $96
Scenario PWEV $341 29% $100
Monte Carlo median $304 18% $54
Peer P/E $212 12% $25
Triangulated 100% $275

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 17.5x 21.2x 25.0x 28.7x 32.5x
6% $182 $221 $260 $299 $338
8% $172 $209 $247 $284 $321
8% $163 $198 $234 $269 $305
10% $154 $188 $222 $256 $290
10% $146 $178 $211 $243 $276

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $154 $178 $203 $227 $251
-1.5pp $166 $192 $218 $244 $270
+0.0pp $178 $206 $234 $262 $290
+1.5pp $192 $221 $251 $281 $311
+3.0pp $206 $237 $269 $301 $333

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Op margin ±3pp $178 $290 $111
Terminal × ±15% $199 $270 $71
Revenue CAGR ±3pp $203 $269 $67
WACC ±1pp $222 $247 $25
FCF conversion ±10% $234 $234 $0

Company lever — SoP/share vs Specialty Chemicals / Coatings multiple (AI re-rating) (base 29x)

Multiple 20.3x 24.6x 29.0x 33.3x 37.7x
SoP/share $1,909 $2,325 $2,751 $3,167 $3,593

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 25×, FY+5 revenue $29B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

A miss on Gross Margin drops the case toward the structural target $146.

Fact / Inference / Speculation

  • FACT: Spot $344; 52-week range $290–$377; engine rating HOLD; base-case target $341 (-1%).
  • INFERENCE: Triangulated FV $275 (-20%). Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.
  • SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 51% of outcome variance.

Recommendation: HOLD

Balanced: triangulated fair value $275 (-20% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (51% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).

Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.